Science Explorer Back to mapMap
Discussion
Researcher · University College London · United Kingdom

Sergio A. Quezada

Sergio A. Quezada publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and CAR-T cell therapy research.

ORCID 0000-0002-9763-1700 OpenAlex
World rank
#5,411
of 7,710,434 ranked researchers
Rank in United Kingdom
#349
of 367,258
Works
400
Citations
39k
Citations per work
96.6
h-index
82
i10-index 143Top 0.9% in Immunology
Sergio A. Quezada

What does Sergio A. Quezada research?

Sergio A. Quezada's work is mostly in Medicine (39%), Immunology and Microbiology (28%), Biochemistry, Genetics and Molecular Biology (16%).

Life Sciences: 176 works · 43.9% of their workImmunology and Microbiology: 112 works · 27.9% of their workImmunology: 112 works · 27.9% of their workBiochemistry, Genetics and Molecular Biology: 64 works · 16.0% of their workMolecular Biology: 34 works · 8.6% of their workCancer Research: 30 works · 7.4% of their workHealth Sciences: 155 works · 38.8% of their workMedicine: 155 works · 38.8% of their workOncology: 107 works · 26.8% of their workPulmonary and Respiratory Medicine: 27 works · 6.8% of their workRadiology, Nuclear Medicine and Imaging: 21 works · 5.2% of their workEverything else: 69 works · 17.3% of their workTHEIR WORKSergio A. Quezada400works
Life Sciences44%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology11227.9%
    2. Biochemistry, Genetics and Molecular Biology6416.0%
    1. Medicine15538.8%
  3. Everything else6917.3%
  1. 1Immunology28% of their works
  2. 2Oncology27% of their works
  3. 3Molecular Biology9% of their works
  4. 4Cancer Research7% of their works
  5. 5Pulmonary and Respiratory Medicine7% of their works
  6. 6Radiology, Nuclear Medicine and Imaging5% of their works

Research topics

Which keywords describe Sergio A. Quezada's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunity, Antigen Presentation, Dendritic Cells, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy1462 topics
  2. Immune Checkpoint Blockade1151 topic
  3. PD-1 and PD-L11151 topic
  4. Immunity1122 topics
  5. Antigen Presentation911 topic
  6. Dendritic Cells911 topic
  7. CAR T Cells551 topic
  8. Chimeric Antigen Receptor551 topic
  9. Cancer Genomics501 topic
  10. Mutational Signatures501 topic
  11. NK Cell Recognition491 topic
  12. Natural Killer Cells491 topic
  13. Foxp3371 topic
  14. TGF-ß371 topic
  15. Fc Receptors291 topic
  16. Therapeutic Antibodies291 topic
  17. Activation211 topic
  18. Macrophage211 topic

Where does Sergio A. Quezada work?

Sergio A. Quezada's main affiliation in the publication record is University College London, United Kingdom.

How many publications and citations does Sergio A. Quezada have?

OpenAlex counts 400 works and 38,634 citations for Sergio A. Quezada, an h-index of 82, ranking #5,411 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sergio A. Quezada. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.